Study future
Hepatitis B
Hepatitis B is a liver infection caused by the hepatitis B virus, which can be transmitted undetected through blood contact, such as during unprotected sex, shared needles or from mother to child during childbirth. Often there are no symptoms at first, so many people do not know they are infected and contagious.
When symptoms of Hepatitis B virus infection do occur, they can range from mild to severe. They often manifest as jaundice, fatigue, nausea and vomiting, abdominal pain, dark urine and light stools. These symptoms may indicate an acute infection, which in some cases may go away on its own.
However, when infection with the Hepatitis B virus becomes chronic, it can lead to serious liver problems such as liver cirrhosis, liver failure or even liver cancer. This constitutes a life-threatening situation because your liver is an organ you cannot live without.
Have you had your liver health tested yet? Whether you have symptoms or not, it is very important for your continued health to know whether or not you are infected with the Hepatitis B virus. You can get tested via a simple blood sample, without obligation, both at our center and at your doctor's office.
New research
Treatment of Hepatitis B depends on the severity of the infection, the presence of liver damage and other individual factors. Although there is currently no cure for Hepatitis B, antiviral medications can potentially suppress the virus and improve quality of life.
We will soon start a groundbreaking clinical trial at ANIMA Research for a new drug that may help prevent liver failure due to chronic infection with the Hepatitis B virus.
Interested in participating? You can sign up for the study soon with no obligation.
Target
- Male or female
- 18+ years
- Chronic hepatitis B (if unknown, this can be tested by simple blood sampling)
Location
ANIMA Research
Science Park 11-13 UHasselt
3590 Diepenbeek, Belgium
Reimbursement
Any participation in a clinical trial will be reimbursed. Specific information on this will be released after application.